Select Parkinson Disease Agent/Select Atypical Antipsychotic
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Medical warning:
Moderate. These medicines may cause some risk when taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Antipsychotic medicines may counteract the effects of medicines used to treat Parkinson disease.
What might happen:
Movement problems or muscle spasms due to Parkinson disease may get worse.
What you should do about this interaction:
Let your healthcare professionals (e.g. doctor or pharmacist) know that you are taking these medicines together.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
References:
1.Requip (ropinirole hydrochloride) US prescribing information. GlaxoSmithKline October, 2006.
2.Sinemet (carbidopa/levodopa) US prescribing information. Merck & Co., Inc February, 2011.
3.Stalevo (carbidopa; entacapone; levodopa) US Prescribing Information. Orion/Novartis October 11, 2010.
4.Marras C, Gruneir A, Wang X, Fischer H, Gill SS, Herrmann N, Anderson GM, Hyson C, Rochon PA. Antipsychotics and mortality in Parkinsonism. Am J Geriatr Psychiatry 2012 Feb;20(2):149-58.
5.Oertel WH Berardelli A Bloem Br etal. Chapter 15 - Late (complicated) Parkinson's disease in European Handbook of Neurological Management. 2011; Volume 1, 2nd Edition:237 - 267.





